💨 Abstract
Neurocrine Biosciences Inc. (NBIX) reported a second-quarter profit of $107.5 million, or $1.06 per share, surpassing Wall Street expectations. The biopharmaceutical company's revenue of $687.5 million also exceeded analysts' forecasts.
Courtesy: WTOP Staff
Suggested
Meta stock surges after Q2 results blow past expectations despite heavy AI spending -
Puerto Rico declares emergency and activates National Guard over water outages -
The Hunt: ‘See Something Say Something’ gets a second look -
Slain Ohio police officer honored with Purple Heart and Medal of Honor during memorial service -
Jury convicts Colorado dentist of first-degree murder in the poisoning death of his wife -
Jarren Duran’s 4 RBIs, Bello’s one-run outing give Boston 13-1 win over Twins in series finale -
Qualcomm: Fiscal Q3 Earnings Snapshot -
Analysis: After NYC shooting, focus returns to ‘see something, say something’ -
Prince George’s Co. swim instructor charged with sexually assaulting children during lessons -